Angiotensin I–converting enzyme–inhibitory peptides from bovine collagen: insights into inhibitory mechanism and transepithelial transport

Food Research International

Volumn 89, Issue , 2016, Pages 373-381

  Fu, Yu ^a   Young, Jette Feveile ^a   Rasmussen, Martin Krøyer ^a   Dalsgaard, Trine Kastrup ^a   Lametsch, René ^b   Aluko, Rotimi E ^c   Therkildsen, Margrethe ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF MANITOBA   (Canada)

Author keywords

angiotensin I converting enzyme; Collagen peptides; digestive enzymes; molecular docking; non competitive inhibition; transepithelial transport

Indexed keywords

COLLAGEN; MAMMALS; MOLECULAR MODELING; PEPTIDES;

ANGIOTENSIN I-CONVERTING ENZYME; COLLAGEN PEPTIDES; COMPETITIVE INHIBITION; DIGESTIVE ENZYMES; MOLECULAR DOCKING; TRANSEPITHELIAL TRANSPORT;

ENZYME INHIBITION;

EID: 85010648342     PISSN: 09639969     EISSN: 18737145     Source Type: Journal    
DOI: 10.1016/j.foodres.2016.08.037     Document Type: Article

References (62)

1. Adibi, S.A., The oligopeptide transporter (Pept-1) in human intestine: Biology and function. Gastroenterology 113:1 (1997), 332–340.
2. Aertgeerts, K., Ye, S., Tennant, M.G., Kraus, M.L., Rogers, J., Sang, B.C., Prasad, G.S., Crystal structure of human dipeptidyl peptidase IV in complex with a decapeptide reveals details on substrate specificity and tetrahedral intermediate formation. Protein Science 13:2 (2004), 412–421.
3. Alemán, A., Gómez-Guillén, M.C., Montero, P., Identification of ace-inhibitory peptides from squid skin collagen after in vitro gastrointestinal digestion. Food Research International 54:1 (2013), 790–795.
4. Aluko, R.E., Antihypertensive Peptides from Food Proteins. Annual Review of Food Science and Technology 6:1 (2015), 235–262.
5. Artursson, P., Palm, K., Luthman, K., Caco-2 monolayers in experimental and theoretical predictions of drug transport. Advanced Drug Delivery Reviews 64:1 (2012), 280–289.
6. Bejjani, S., Wu, J., Transport of IRW, an Ovotransferrin-Derived Antihypertensive Peptide, in Human Intestinal Epithelial Caco-2 Cells. Journal of Agricultural and Food Chemistry 61:7 (2013), 1487–1492.
7. Chaudhary, S., Vats, I.D., Chopra, M., Biswas, P., Pasha, S., Effect of varying chain length between P-1 and P-1 ‘ position of tripeptidomimics on activity of angiotensin-converting enzyme inhibitors. Bioorganic & Medicinal Chemistry Letters 19:15 (2009), 4364–4366.
8. Conradi, R.A., Wilkinson, K.F., Rush, B.D., Hilgers, A.R., Ruwart, M.J., Burton, P.S., In vitro/in vivo models for peptide oral absorption: Comparison of Caco-2 cell permeability with rat intestinal absorption of renin inhibitory peptides. Pharmaceutical Research 10:12 (1993), 1790–1792.
9. Crowley, S.D., Coffman, T.M., Recent advances involving the renin–angiotensin system. Experimental Cell Research 318:9 (2012), 1049–1056.
10. Daien, V., Duny, Y., Ribstein, J., Cailar, G.d., Mimran, A., Villain, M., Fesler, P., Treatment of Hypertension With Renin–Angiotensin System Inhibitors and Renal Dysfunction: A Systematic Review and Meta-Analysis. American Journal of Hypertension 25:1 (2012), 126–132.
11. D'Atri, F., Citi, S., Molecular complexity of vertebrate tight junctions (Review). Molecular Membrane Biology 19:2 (2002), 103–112.
12. del Mar Contreras, M., Sanchez, D., Sevilla, M.Á., Recio, I., Amigo, L., Resistance of casein-derived bioactive peptides to simulated gastrointestinal digestion. International Dairy Journal 32:2 (2013), 71–78.
13. Dempe, J.S., Scheerle, R.K., Pfeiffer, E., Metzler, M., Metabolism and permeability of curcumin in cultured Caco-2 cells. Molecular Nutrition & Food Research 57:9 (2013), 1543–1549.
14. Ding, L., Zhang, Y., Jiang, Y., Wang, L., Liu, B., Liu, J., Transport of egg white ACE-inhibitory peptide, Gln-Ile-Gly-Leu-Phe, in human intestinal Caco-2 cell monolayers with cytoprotective effect. Journal of Agricultural and Food Chemistry 62:14 (2014), 3177–3182.
15. Escudero, E., Angel Sentandreu, M., Arihara, K., Toldra, F., Angiotensin I-Converting Enzyme Inhibitory Peptides Generated from in Vitro Gastrointestinal Digestion of Pork Meat. Journal of Agricultural and Food Chemistry 58:5 (2010), 2895–2901.
16. Escudero, E., Mora, L., Fraser, P.D., Aristoy, M.-C., Arihara, K., Toldrá, F., Purification and Identification of antihypertensive peptides in Spanish dry-cured ham. Journal of Proteomics 78 (2013), 499–507.
17. Escudero, E., Mora, L., Toldra, F., Stability of ACE inhibitory ham peptides against heat treatment and in vitro digestion. Food Chemistry 161 (2014), 305–311.
18. Escudero, E., Toldra, F., Sentandreu, M.A., Nishimura, H., Arihara, K., Antihypertensive activity of peptides identified in the in vitro gastrointestinal digest of pork meat. Meat Science 91:3 (2012), 382–384.
19. Fahmi, A., Morimura, S., Guo, H.C., Shigematsu, T., Kida, K., Uemura, Y., Production of angiotensin I converting enzyme inhibitory peptides from sea bream scales. Process Biochemistry 39:10 (2004), 1195–1200.
20. Fitzgerald, M.A., Hypertension treatment update: Focus on direct renin inhibition. Journal of the American Academy of Nurse Practitioners 23:5 (2011), 239–248.
21. Fu, Y., Young, J.F., Dalsgaard, T.K., Therkildsen, M., Separation of angiotensin I-converting enzyme inhibitory peptides from bovine connective tissue and their stability towards temperature, pH and digestive enzymes. International Journal of Food Science and Technology 50:5 (2015), 1234–1243.
22. Fu, Y., Young, J.F., Løkke, M.M., Lametsch, R., Aluko, R.E., Therkildsen, M., Revalorisation of bovine collagen as a potential precursor of angiotensin I-converting enzyme (ACE) inhibitory peptides based on in silico and in vitro protein digestions. Journal of Functional Foods 24 (2016), 196–206.
23. Gallego, M., Grootaert, C., Mora, L., Aristoy, M.C., Van Camp, J., Toldrá, F., Transepithelial transport of dry-cured ham peptides with ACE inhibitory activity through a Caco-2 cell monolayer. Journal of Functional Foods 21 (2016), 388–395.
24. Girgih, A.T., He, R., Aluko, R.E., Kinetics and molecular docking studies of the inhibitions of angiotensin converting enzyme and renin activities by hemp Seed (Cannabis sativa L.) peptides. Journal of Agricultural and Food Chemistry 62:18 (2014), 4135–4144.
25. Gómez-Guillén, M.C., Giménez, B., López-Caballero, M.E., Montero, M.P., Functional and bioactive properties of collagen and gelatin from alternative sources: A review. Food Hydrocolloids 25:8 (2011), 1813–1827.
26. Gu, Y., Wu, J., LC-MS/MS coupled with QSAR modeling in characterising of angiotensin I-converting enzyme inhibitory peptides from soybean proteins. Food Chemistry 141:3 (2013), 2682–2690.
27. He, R., Aluko, R.E., Ju, X.-R., Evaluating molecular mechanism of hypotensive peptides interactions with renin and angiotensin converting enzyme. PloS One, 9(3), 2014, e91051.
28. Hidalgo, I.J., Raub, T.J., Borchardt, R.T., Characterization of the human-colon carcinoma cell-line (caco-2) as a model system for intestinal epithelial permeability. Gastroenterology 96:3 (1989), 736–749.
29. Himaya, S.W.A., Ngo, D.-H., Ryu, B., Kim, S.-K., An active peptide purified from gastrointestinal enzyme hydrolysate of Pacific cod skin gelatin attenuates angiotensin-1 converting enzyme (ACE) activity and cellular oxidative stress. Food Chemistry 132:4 (2012), 1872–1882.
30. Israili, Z.H., Hall, W.D., Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy: a review of the literature and pathophysiology. Annals of Internal Medicine 117:3 (1992), 234–242.
31. Jayathilakan, K., Sultana, K., Radhakrishna, K., Bawa, A., Utilization of byproducts and waste materials from meat, poultry and fish processing industries: a review. Journal of Food Science and Technology 49:3 (2012), 278–293.
32. Lafarga, T., O'Connor, P., Hayes, M., Identification of novel dipeptidyl peptidase-IV and angiotensin-I-converting enzyme inhibitory peptides from meat proteins using in silico analysis. Peptides 59:0 (2014), 53–62.
33. Lee, J.K., Jeon, J.-K., Byun, H.-G., Effect of angiotensin I converting enzyme inhibitory peptide purified from skate skin hydrolysate. Food Chemistry 125:2 (2011), 495–499.
34. Lei, L., Sun, H., Liu, D., Liu, L., Li, S., Transport of Val-Leu-Pro-Val-Pro in human intestinal epithelial (Caco-2) cell monolayers. Journal of Agricultural and Food Chemistry 56:10 (2008), 3582–3586.
35. Martínez-Maqueda, D., Miralles, B., Recio, I., Hernández-Ledesma, B., Antihypertensive peptides from food proteins: a review. Food & Function 3:4 (2012), 350–361.
36. Miguel, M., Dávalos, A., Manso, M.A., de la Peña, G., Lasunción, M.A., López-Fandiño, R., Transepithelial transport across Caco-2 cell monolayers of antihypertensive egg-derived peptides. PepT1-mediated flux of Tyr-Pro-Ile. Molecular Nutrition & Food Research 52:12 (2008), 1507–1513.
37. Mora, L., Reig, M., Toldra, F., Bioactive peptides generated from meat industry by-products. Food Research International 65 (2014), 344–349.
38. Mosmann, T., Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of Immunological Methods 65:1–2 (1983), 55–63.
39. Natesh, R., Schwager, S.L.U., Evans, H.R., Sturrock, E.D., Acharya, K.R., Structural Details on the binding of antihypertensive drugs captopril and enalaprilat to human testicular angiotensin I-converting enzyme. Biochemistry 43:27 (2004), 8718–8724.
40. Natesh, R., Schwager, S.L.U., Sturrock, E.D., Acharya, K.R., Crystal structure of the human angiotensin-converting enzyme-lisinopril complex. Nature 421:6922 (2003), 551–554.
41. Ni, H., Li, L., Liu, G., Hu, S.-Q., Inhibition Mechanism and Model of an Angiotensin I-Converting Enzyme (ACE)-Inhibitory Hexapeptide from Yeast (Saccharomyces cerevisiae). PloS One, 7(5), 2012, e37077.
42. Pauletti, G.M., Gangwar, S., Knipp, G.T., Nerurkar, M.M., Okumu, F.W., Tamura, K., Borchardt, R.T., Structural requirements for intestinal absorption of peptide drugs. Journal of Controlled Release 41:1 (1996), 3–17.
43. Petrat-Melin, B., Andersen, P., Rasmussen, J.T., Poulsen, N.A., Larsen, L.B., Young, J.F., In vitro digestion of purified β-casein variants A1, A2, B, and I: Effects on antioxidant and angiotensin-converting enzyme inhibitory capacity. Journal of Dairy Science 98:1 (2015), 15–26.
44. Pina, A.S., Roque, A.C.A., Studies on the molecular recognition between bioactive peptides and angiotensin-converting enzyme. Journal of Molecular Recognition 22:2 (2009), 162–168.
45. Pokora, M., Zambrowicz, A., Dabrowska, A., Eckert, E., Setner, B., Szoltysik, M., Chrzanowska, J., An attractive way of egg white protein by-product use for producing of novel anti-hypertensive peptides. Food Chemistry 151 (2014), 500–505.
46. Quirós, A., Dávalos, A., Lasunción, M.A., Ramos, M., Recio, I., Bioavailability of the antihypertensive peptide LHLPLP: Transepithelial flux of HLPLP. International Dairy Journal 18:3 (2008), 279–286.
47. Quirós, A., del Mar Contreras, M., Ramos, M., Amigo, L., Recio, I., Stability to gastrointestinal enzymes and structure–activity relationship of β-casein-peptides with antihypertensive properties. Peptides 30:10 (2009), 1848–1853.
48. Rawendra, R.D., Chang, C.-I., Chen, H.-H., Huang, T.-C., Hsu, J.-L., A novel angiotensin converting enzyme inhibitory peptide derived from proteolytic digest of Chinese soft-shelled turtle egg white proteins. Journal of Proteomics 94 (2013), 359–369.
49. Regazzo, D., Mollé, D., Gabai, G., Tomé, D., Dupont, D., Leonil, J., Boutrou, R., The (193–209) 17-residues peptide of bovine β-casein is transported through Caco-2 monolayer. Molecular Nutrition & Food Research 54:10 (2010), 1428–1435.
50. Satake, M., Enjoh, M., Nakamura, Y., Takano, T., Kawamura, Y., Arai, S., Shimizu, M., Transepithelial Transport of the Bioactive Tripeptide, Val-Pro-Pro, in Human Intestinal Caco-2 Cell Monolayers. Bioscience, Biotechnology, and Biochemistry 66:2 (2002), 378–384.
51. Shanmugam, V.P., Kapila, S., Sonfack, T.K., Kapila, R., Antioxidative peptide derived from enzymatic digestion of buffalo casein. International Dairy Journal 42 (2015), 1–5.
52. Sharp, S.I., Aarsland, D., Day, S., Sonnesyn, H., Ballard, C., Alzheimer's Soc Vasc Dementia, S., Hypertension is a potential risk factor for vascular dementia: systematic review. International Journal of Geriatric Psychiatry 26:7 (2011), 661–669.
53. Sheih, I.C., Fang, T.J., Wu, T.-K., Isolation and characterisation of a novel angiotensin I-converting enzyme (ACE) inhibitory peptide from the algae protein waste. Food Chemistry 115:1 (2009), 279–284.
54. Shimizu, M., Tsunogai, M., Arai, S., Transepithelial transport of oligopeptides in the human intestinal cell, Caco-2. Peptides 18:5 (1997), 681–687.
55. Shiozaki, K., Shiozaki, M., Masuda, J., Yamauchi, A., Ohwada, S., Nakano, T., Sato, M., Identification of oyster-derived hypotensive peptide acting as angiotensin-I-converting enzyme inhibitor. Fisheries Science 76:5 (2010), 865–872.
56. Vermeirssen, V., Augustijns, P., Morel, N., Van Camp, J., Opsomer, A., Verstraete, W., In vitro intestinal transport and antihypertensive activity of ACE inhibitory pea and whey digests. International Journal of Food Sciences and Nutrition 56:6 (2005), 415–430.
57. Vij, R., Reddi, S., Kapila, S., Kapila, R., Transepithelial transport of milk derived bioactive peptide VLPVPQK. Food Chemistry 190 (2016), 681–688.
58. Wu, Q., Cai, Q.-F., Tao, Z.-P., Sun, L.-C., Shen, J.-D., Zhang, L.-J., Cao, M.-J., Purification and characterization of a novel angiotensin I-converting enzyme inhibitory peptide derived from abalone (Haliotis discus hannai Ino) gonads. European Food Research and Technology 240:1 (2015), 137–145.
59. Wu, Q., Du, J., Jia, J., Kuang, C., Production of ACE inhibitory peptides from sweet sorghum grain protein using alcalase: Hydrolysis kinetic, purification and molecular docking study. Food Chemistry 199 (2016), 140–149.
60. Xiang, D., Fengfeng, W., Mei, L., Na, Y., Chunsen, W., Yamei, J., Xueming, X., Naturally occurring angiotensin I-converting enzyme inhibitory peptide from a fertilized egg and its inhibitory mechanism. Journal of Agricultural and Food Chemistry 62:24 (2014), 5500–5506.
61. Xu, J., Wei, L., Mathvink, R., He, J., Park, Y.-J., He, H., Patel, R.A., Discovery of potent and selective phenylalanine based dipeptidyl peptidase IV inhibitors. Bioorganic & Medicinal Chemistry Letters 15:10 (2005), 2533–2536.
62. Zambrowicz, A., Timmer, M., Polanowski, A., Lubec, G., Trziszka, T., Manufacturing of peptides exhibiting biological activity. Amino acids 44:2 (2013), 315–320.